Largest pharmaceutical companies in the United States by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 44 pharmaceutical companies in the United States ranked by total liabilities, at DKK 935.3B, ahead of Pfizer (DKK 827.5B) and Johnson & Johnson (DKK 802.2B). Figures as of 20 Nov 2026, 10:50 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- AbbVieDKK 935.3B
- Median
- DKK 5.7B
- Combined market value
- DKK 25.47T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | DKK 935.3B | DKK 3.42T | DKK 1,933.01 | 0.86% down | 25% up | ||
| 2 | PfizerPFE · Health Care | DKK 827.5B | DKK 1.07T | DKK 187.75 | 1.85% down | 15% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | DKK 802.2B | DKK 4.38T | DKK 1,821.20 | 2.04% down | 34% up | ||
| 4 | Eli LillyLLY · Health Care | DKK 585.9B | DKK 8.2T | DKK 9,211.14 | 2.29% down | 33% up | ||
| 5 | Merck & CoMRK · Health Care | DKK 574.1B | DKK 2.23T | DKK 905.42 | 3.61% down | 45% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | DKK 487.7B | DKK 813B | DKK 397.73 | 2.05% down | 30% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | DKK 231.4B | DKK 1.23T | DKK 708.12 | 0.58% down | 16% down | ||
| 8 | ViatrisVTRS · Health Care | DKK 153.3B | DKK 155.4B | DKK 135.53 | 1.97% down | 99% up | ||
| 9 | ZoetisZTS · Health Care | DKK 82.7B | DKK 223.8B | DKK 550.78 | 5.59% down | 26% down | ||
| 10 | Royalty PharmaRPRX · Health Care | DKK 67.5B | DKK 265.5B | DKK 461.68 | 1.38% down | 79% up | ||
| 11 | Regeneron PharmaceuticalsREGN · Health Care | DKK 63.4B | DKK 651.2B | DKK 6,294.79 | 2.35% down | 28% up | ||
| 12 | Vertex PharmaceuticalsVRTX · Health Care | DKK 47.6B | DKK 899.9B | DKK 3,549.55 | 2.94% down | 27% up | ||
| 13 | Elanco Animal HealthELAN · Health Care | DKK 46.4B | DKK 89.6B | DKK 179.23 | 1.54% down | 26% up | ||
| 14 | Alnylam PharmaceuticalsALNY · Health Care | DKK 28.5B | DKK 135B | DKK 1,007.75 | 1.06% down | 66% down | ||
| 15 | Amneal PharmaceuticalsAMRX · Health Care | DKK 25B | DKK 50.8B | DKK 145.82 | 2.24% down | 90% up | ||
| 16 | PTC TherapeuticsPTCT · Health Care | DKK 21.2B | DKK 33.2B | DKK 397.63 | 3.16% down | 21% down | ||
| 17 | Ionis PharmaceuticalsIONS · Health Care | DKK 20.7B | DKK 30.9B | DKK 185.57 | 0.62% down | 63% down | ||
| 18 | BridgeBio PharmaBBIO · Health Care | DKK 20.5B | DKK 103.8B | DKK 532.99 | 0.22% up | 21% up | ||
| 19 | CytokineticsCYTK · Health Care | DKK 14.2B | DKK 48.9B | DKK 350.82 | 0.27% up | 19% down | ||
| 20 | InsmedINSM · Health Care | DKK 10.4B | DKK 216.1B | DKK 984.84 | 20.58% up | 40% down | ||
| 21 | BioMarin PharmaceuticalBMRN · Health Care | DKK 10.3B | DKK 81.1B | DKK 418.73 | 0.02% down | 17% up | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 6B | DKK 42.1B | DKK 297.58 | 1.25% up | 13% up | ||
| 23 | United TherapeuticsUTHR · Health Care | DKK 5.3B | DKK 162.3B | DKK 3,811.61 | 3.16% down | 22% up | ||
| 24 | Legend BiotechLEGN · Health Care | DKK 5B | DKK 21.3B | DKK 109.76 | 0.92% down | 41% down | ||
| 25 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 4.5B | DKK 62.8B | DKK 2,704.74 | 0.34% down | 27% down | ||
| 26 | Axsome TherapeuticsAXSM · Health Care | DKK 4.1B | DKK 48.7B | DKK 924.99 | 1.25% up | 6% down | ||
| 27 | Ligand PharmaceuticalsLGND · Health Care | DKK 3.7B | DKK 39.1B | DKK 1,956.19 | 3.94% down | 50% up | ||
| 28 | Mirum PharmaceuticalsMIRM · Health Care | DKK 3.6B | DKK 42.5B | DKK 651.13 | 3.27% up | 34% up | ||
| 29 | Travere TherapeuticsTVTX · Health Care | DKK 3.3B | DKK 31.6B | DKK 329.28 | 3.86% down | 45% up | ||
| 30 | TG TherapeuticsTGTX · Health Care | DKK 2.8B | DKK 66.9B | DKK 442.31 | 1.88% down | 117% up | ||
| 31 | Cogent BiosciencesCOGT · Health Care | DKK 2.1B | DKK 32.9B | DKK 189.11 | 0.25% down | 20% down | ||
| 32 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 1.4B | DKK 55.2B | DKK 796.27 | 1.88% down | 18% up | ||
| 33 | Corcept TherapeuticsCORT · Health Care | DKK 1.3B | DKK 48.5B | DKK 443.00 | 4.15% down | 10% down | ||
| 34 | Definium TherapeuticsDFTX · Health Care | DKK 734.7M | DKK 27.5B | DKK 200.98 | 1.24% up | 168% up | ||
| 35 | Summit TherapeuticsSMMT · Health Care | DKK 629.4M | DKK 57.6B | DKK 72.06 | 0.67% up | 36% down | ||
| 36 | ErascaERAS · Health Care | DKK 483.9M | DKK 34B | DKK 96.94 | 3.34% up | 395% up | ||
| 37 | Spyre TherapeuticsSYRE · Health Care | DKK 426.4M | DKK 63.2B | DKK 665.58 | 3.77% down | 332% up | ||
| 38 | Praxis Precision MedicinesPRAX · Health Care | DKK 407.5M | DKK 59.2B | DKK 2,119.53 | 1.87% up | 86% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | DKK 364.6M | DKK 55.2B | DKK 845.50 | 2.47% down | 51% up | ||
| 40 | Dianthus TherapeuticsDNTH · Health Care | DKK 255.8M | DKK 32.6B | DKK 578.32 | 1.01% up | 108% up | ||
| 41 | Edgewise TherapeuticsEWTX · Health Care | DKK 206.9M | DKK 30.7B | DKK 280.67 | 0.48% down | 86% up | ||
| 42 | Oruka TherapeuticsORKA · Health Care | DKK 113.8M | DKK 45.1B | DKK 665.17 | 1.91% up | 255% up | ||
| 43 | Belite BioBLTE · Health Care | DKK 68.7M | DKK 41.8B | DKK 1,029.57 | 3.33% down | 43% up | ||
| 44 | VeradermicsMANE · Health Care | DKK 62.4M | DKK 35.8B | DKK 848.02 | 0.38% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8174 DKK).
Questions and answers
Which pharmaceutical companies in the United States rank first by total liabilities?
AbbVie (DKK 935.3B), Pfizer (DKK 827.5B) and Johnson & Johnson (DKK 802.2B) are the top three of the 44 pharmaceutical companies in the United States ranked by total liabilities as of 20 Nov 2026, 10:50 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by total liabilities.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by total liabilities have a combined market value of DKK 25.47T as of 20 Nov 2026, 10:50 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by total liabilities”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.